Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
30
OFIX Quote, Financials, Valuation and Earnings
Last price:
$17.31
Seasonality move
:
7.1%
Day range:
$17.12 - $17.56
52-week range:
$12.08 - $20.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.84x
P/B ratio:
1.26x
Volume:
159.5K
Avg. volume:
277.7K
1-year change:
21.96%
Market cap:
$662.3M
Revenue:
$746.6M
EPS (TTM):
-$3.13
Analysts' Opinion
-
Consensus RatingOrthofix Medical has received a consensus rating of . The company's average rating is a based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Orthofix Medical has an estimated upside of 40.8% from its current price of $17.33.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $17.33.
Fair Value
-
According to the consensus of 0 analysts, Orthofix Medical has 40.8% upside to fair value with a price target of -- per share.
OFIX vs. S&P 500
-
Over the past 5 trading days, Orthofix Medical has underperformed the S&P 500 by -5.42% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Orthofix Medical does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Orthofix Medical has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Orthofix Medical reported revenues of $196.6M.
Earnings Growth
-
Orthofix Medical has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Orthofix Medical reported earnings per share of -$0.71.
Enterprise value:
750.7M
EV / Invested capital:
1.16x
Price / LTM sales:
0.84x
EV / EBIT:
--
EV / Revenue:
0.96x
PEG ratio (5yr expected):
-0.11x
EV / Free cash flow:
-16.31x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$533.7M
Return On Assets:
-13.26%
Net Income Margin (TTM):
-15.18%
Return On Equity:
-20.83%
Return On Invested Capital:
-17.63%
Operating Margin:
-8.61%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $463.5M | $668.5M | $784.2M | $184M | $196.6M | |
| Gross Profit | $339.8M | $438.8M | $533.7M | $119.8M | $135.1M | |
| Operating Income | -$16.8M | -$125M | -$77.3M | -$25.2M | -$16.9M | |
| EBITDA | $13.4M | -$77.5M | -$31.3M | -$12.5M | -$4.6M | |
| Diluted EPS | -$2.28 | -$3.90 | -$3.13 | -$0.77 | -$0.71 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $254.7M | $260.2M | $246.9M | $393.7M | $386.2M | |
| Total Assets | $517.1M | $500.4M | $449.7M | $905.7M | $867.9M | |
| Current Liabilities | $93.4M | $80M | $77.6M | $152.5M | $161.9M | |
| Total Liabilities | $162.2M | $135.6M | $116.1M | $290.2M | $341.9M | |
| Total Equity | $354.9M | $364.8M | $333.5M | $615.5M | $525.9M | |
| Total Debt | -- | -- | -- | $70M | $118.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.1M | -$36.7M | -$4.6M | $477K | $11.7M | |
| Cash From Investing | -$27.6M | -$24M | -$41.5M | -$22.3M | -$5.9M | |
| Cash From Financing | $476K | $41.5M | $44.5M | $18.3M | -$2.5M | |
| Free Cash Flow | -$26.2M | -$89.6M | -$46M | -$21.9M | $5.9M | |
OFIX
Sector
Market Cap
$662.3M
$45.6M
Price % of 52-Week High
83.6%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
-3.28%
-0.74%
1-Year Price Total Return
21.96%
-31.35%
Beta (5-Year)
1.087
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$17.69
200-day SMA
Buy
Level
$15.54
Bollinger Bands (100)
Buy
Level
15.66 - 18.28
Chaikin Money Flow
Buy
Level
20.5M
20-day SMA
Sell
Level
$18.42
Relative Strength Index (RSI14)
Sell
Level
39.38
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-81.7822
50-day SMA
Sell
Level
$17.75
MACD (12, 26)
Sell
Level
-0.18
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
36.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3317)
Buy
CA Score
(Annual)
Level (-0.1454)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (0.0123)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Stock Forecast FAQ
In the current month, OFIX has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The OFIX average analyst price target in the past 3 months is --.
-
Where Will Orthofix Medical Stock Be In 1 Year?
According to analysts, the consensus estimate is that Orthofix Medical share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Orthofix Medical?
Analysts are divided on their view about Orthofix Medical share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Orthofix Medical is a Sell and believe this share price will drop from its current level to --.
-
What Is Orthofix Medical's Price Target?
The price target for Orthofix Medical over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is OFIX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Orthofix Medical is a . 0 of 0 analysts rate the stock a at this time.
-
How Can I Buy Shares Of OFIX?
You can purchase shares of Orthofix Medical via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Orthofix Medical shares.
-
What Is The Orthofix Medical Share Price Today?
Orthofix Medical was last trading at $17.31 per share. This represents the most recent stock quote for Orthofix Medical. Yesterday, Orthofix Medical closed at $17.33 per share.
-
How To Buy Orthofix Medical Stock Online?
In order to purchase Orthofix Medical stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 7.34% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.68% over the past day.
